Research Presentation Sessions: Oncologic Imaging

RPS 1316 - Advanced imaging for oncology staging and follow-up

Lectures

1
Introduction by the moderator

Introduction by the moderator

02:00Marius E. Mayerhöfer, Vienna / AT

2
A novel non-invasive approach to cancer of unknown primary: AI can detect CT morphological differences between primary tumours and metastases across tumour types

A novel non-invasive approach to cancer of unknown primary: AI can detect CT morphological differences between primary tumours and metastases across tumour types

08:00Zuhir Elkarghali, Amsterdam / NL

3
Magnetic resonance imaging (MRI) for staging melanoma patients in direct comparison to computed tomography (CT): results from a prospective positron-emission tomography PET/CT and PET/MRI study

Magnetic resonance imaging (MRI) for staging melanoma patients in direct comparison to computed tomography (CT): results from a prospective positron-emission tomography PET/CT and PET/MRI study

08:00Cecilia Zhang, Tuebingen / DE

4
Identification of early CT imaging response predictors after CAR T-cell therapy

Identification of early CT imaging response predictors after CAR T-cell therapy

08:00Michael Winkelmann, Munich / DE

5
CT‑based radiomics score of PET-negative residual CT Masses: a potential biomarker for the prediction of relapse‑free survival in lymphoma patients showing complete metabolic response

CT‑based radiomics score of PET-negative residual CT Masses: a potential biomarker for the prediction of relapse‑free survival in lymphoma patients showing complete metabolic response

08:00Seung Ha Cha, Seoul, Seocho-gu / KR

6
Preliminary whole-body MRI study for evaluation of minimal residual disease in a group of multiple myeloma patients

Preliminary whole-body MRI study for evaluation of minimal residual disease in a group of multiple myeloma patients

08:00Valentina Angelini, Napoli / IT

7
Ultra low dose whole-body computed tomography protocol optimisation for patients with plasma cell disorders: diagnostic accuracy and effective dose analysis from a reference centre

Ultra low dose whole-body computed tomography protocol optimisation for patients with plasma cell disorders: diagnostic accuracy and effective dose analysis from a reference centre

08:00Davide Tore, Asti / IT

8
Iodine quantification on multi-vendor DECT platforms: inter-scanner variability and impact of normalisation

Iodine quantification on multi-vendor DECT platforms: inter-scanner variability and impact of normalisation

08:00Simon Lennartz, Köln / DE

9
Investigating the validity of computed tomography low dose simulations in a prospective intra-individual in-vivo real low dose animal study on a 3rd generation dual-source scanner

Investigating the validity of computed tomography low dose simulations in a prospective intra-individual in-vivo real low dose animal study on a 3rd generation dual-source scanner

08:00Andreas Brendlin, Tübingen / DE

10
Optimal keV in virtual monoenergetic imaging reconstructions for the detection of hypovascularized liver metastases on a novel photon counting dual-source CT scanner: initial experience

Optimal keV in virtual monoenergetic imaging reconstructions for the detection of hypovascularized liver metastases on a novel photon counting dual-source CT scanner: initial experience

08:00Josua Decker, Augsburg / DE

11
Feasibility and dose evaluation of a dynamic liver perfusion CT protocol with latest generation scanner

Feasibility and dose evaluation of a dynamic liver perfusion CT protocol with latest generation scanner

08:00Federica Ullo, Torino / IT